SRSF1 and obesity disorder: A small molecule, ABX300, has been identified as a potential therapeutic agent capable of mitigating diet-induced obesity by modulating LMNA isoform expression through the regulation of serine/arginine-rich splicing factor 1 (SRSF1) in HFD-fed mice [105].